Seagen
SGEN
$228.74
Share price
-0.07%
Change (1 day)
68.92%
Change (1 year)
Categories
Seagen (SGEN) - P/B ratio
P/B ratio as of April 2024 : 16.9
According to Seagen
's latest financial reports the company has a price-to-book ratio of 16.9.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Seagen - P/B ratio (from 2001 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 8.51 | -7.73% |
| 2021-12-31 | 9.22 | 2.62% |
| 2020-12-31 | 8.99 | -14.19% |
| 2019-12-31 | 10.5 | 46.94% |
| 2018-12-31 | 7.13 | -37.28% |
| 2017-12-31 | 11.4 | -3.53% |
| 2016-12-31 | 11.8 | 28.9% |
| 2015-12-31 | 9.14 | -51.63% |
| 2014-12-31 | 18.9 | -11.09% |
| 2013-12-31 | 21.2 | 73.25% |
| 2012-12-31 | 12.3 | 39.62% |
| 2011-12-31 | 8.78 | -6.6% |
| 2010-12-31 | 9.40 | 89.82% |
| 2009-12-31 | 4.95 | -48.85% |
| 2008-12-31 | 9.69 | -32.07% |
| 2007-12-31 | 14.3 | 362.56% |
| 2006-12-31 | 3.08 | 16.28% |
| 2005-12-31 | 2.65 | 0.4% |
| 2004-12-31 | 2.64 | -28.06% |
| 2003-12-31 | 3.67 | 80.15% |
| 2002-12-31 | 2.04 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 1.67 | -90.15% | 🇺🇸 USA |
 AbbVie ABBV | 28.6 | 68.89% | 🇺🇸 USA |
 Biogen BIIB | 1.99 | -88.25% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 3.36 | -80.15% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 5.13 | -69.67% | 🇬🇧 UK |
 Spectrum Pharmaceuticals
SPPI | 7.89 | -53.39% | 🇺🇸 USA |
 ImmunoGen
IMGN | 15.5 | -8.19% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | 5.67 | -66.51% | 🇺🇸 USA |